其他报告

【其他报告】Trigonelline Is a Novel NAD+ Precursor with Muscle Longevity Benefits Across Species

发布时间:2023-10-23  阅读次数:910

报告人:Vincenzo Sorrentino (National University of Singapore, NUS)

时  间:2023年10月27日 14:00

地  点:新葡的京集团8814A楼0-103

 

Vincenzo Sorrentino is an Italian-born scientist in the fields of aging, mitochondrial biology and neuromuscular degeneration. After his PhD with honors obtained at the University of Amsterdam in medical biochemistry, he carried his postdoctoral research at the EPFL in Switzerland.

His work focused on mitochondria and NAD+ metabolism in Alzhimer's disease and muscle aging, with his discoveries appearing in Nature (2017) and Cell Reports (2021). From 2019 till 2022, he took a role as Group Leader at the Nestle Institute of Health Sciences in Switzerland, to lead research focused on integrating basic discoveries on natural bioactives that modulate NAD+, mitochondria and protein homeostasis with their possible translation into clinical applications.

Currently, he is an Assistant Professor and has launched his lab at the NUS with the Dept. of Biochemistry and the Healthy Longevity Transitional Research Program, Yong Loo Lin School of Medicine, and holds an affiliation as an Adjunct Assistant Professor at the University of Amsterdam.

Copyright 2016 新葡的京集团8814(中国)股份公司    访问旧版
地址:上海市闵行区东川路800号 电话:021 - 34205866 备案:沪交ICP备20101025